
The 12-week randomized, double-blind, placebo-controlled trial evaluated the safety and efficacy of a novel oral nutraceutical in women with mild-to-moderate acne. Compared to placebo, the supplement significantly improved acne severity (IGA scores), lesion counts, and overall skin health. Results support its potential as a safe adjunctive therapy targeting inflammatory pathways in acne management for adult women.
Like
Save
Share